Background Increased serum creatinine(SCr)was common after cardiac surgery and associated with poor outcomes.However,the prognostic role of postoperative SCr level measured on the morning of the first day was unclear ...Background Increased serum creatinine(SCr)was common after cardiac surgery and associated with poor outcomes.However,the prognostic role of postoperative SCr level measured on the morning of the first day was unclear in middle-aged and aged patients with rheumatic heart disease(RHD)undergoing valve replacement surgery(VRS).Methods Consecutive middle-aged and aged patients(age≥45 years)diagnosed with RHD undergoing at least one valve replacement were enrolled.Patients were routinely taken into the intensive care unit(ICU)for special care within 1 hour after VRS.SCr was measured at ICU admission and on the first day morning(within 24 hours).Association of postoperative SCr level with in-hospital and one-year mortality was analyzed.Results 3919 patients were finally included and divided into 4 groups according to the quartiles of postoperative SCr level on the first day morning:<1.0 mg/d L(n=1064),1.0-1.2 mg/d L(n=892),1.2-1.5 mg/d L(n=956)and≥1.5 mg/d L(n=1007).SCr level measured on the first day morning following surgery was an independent predictor for in-hospital mortality(adjusted OR:3.42,95%CI:2.52-4.63,P<0.001)and 1-year mortality(adjusted HR:2.99,95%CI:2.32-3.86,P<0.001).SCr level measured at this time had a greater predictive power for inhospital mortality than that measured at the time of ICU admission after surgery(P<0.001).Cumulative one-year mortality was significantly higher in patients with upper postoperative SCr quartiles on the first day morning(Logrank:125.75,P<0.001).Conclusions Postoperative SCr level measured on the first day morning could serve as an early and powerful prognostic marker for in-hospital and one-year mortality in middle-aged and aged RHD patients undergoing VRS.Attention should be paid to RHD patients with increased postoperative SCr level within24 hours after surgery.展开更多
INTRODUCTION With the development of economy and improvement of life quality,the incidences of hypertension,hyper-cholesterolemia,diabetes,obesity and smoking have been increased in China,which has led to a significan...INTRODUCTION With the development of economy and improvement of life quality,the incidences of hypertension,hyper-cholesterolemia,diabetes,obesity and smoking have been increased in China,which has led to a significant increase in the morbidity and mortality of coronary artery disease（CAD）~1.Since it was introduced into China in 1984,coronary intervention（PCI）has developed rapidly and has become the major treatment of CAD because of its unique characteristics of minimal invasive and effective outcome.展开更多
Background The suitable time for treating patients with acute ST elevation myocardial infarction （STEMI） is unclear. This study was to investigate the effects of reperfusion therapy at different late times on patien...Background The suitable time for treating patients with acute ST elevation myocardial infarction （STEMI） is unclear. This study was to investigate the effects of reperfusion therapy at different late times on patients with acute STEMI, in order to decide the best time for late reperfusion therapy by providing evidence-based treatment in clinical practice. Methods We enrolled 1372 patients with STEMI and receiving selective percutaneous coro- nary intervention therapy between January 1st, 2010 to December 30th, 2014. According to the time receiving PCI, these patients were divided into 3 groups： 〈3 d（n=66） ,3-6 d（n=388） and/〉7 d （n=918）. The demograph- ic, clinical and coronary angiography data, and in-hospital major adverse clinical events （MACEs） were com- pared. Results The mortality rates among 3 groups were not statistically different （0 vs. 2.6% vs. 2.0%, P= 0.375）. The incidence rate of in-hospital MACEs in 3-6 d group was lower than the other two groups, but not sta- tistic difference （25.8% vs. 16.8% vs. 21.6%, P=0.077）. By comparing the cost of hospitalization, we found that the 3-6 d group was slight lower. For patients with non-occlusive culprit vessels, although the mortality rate still had no statistic difference, the incidence rates of in-hospital MACEs were different （33.3% vs. 11.7% vs. 15.9%, P=0.003）. However, the same conclusion was not driven in patients with occlusive target vessels. Conclusions For patients with STEMI receiving late reperfusion therapy, intervention during 3-6 d might have a trend to improve prognosis.展开更多
基金supported by grants from Medical Science and Technology Research Funding of Guangdong (No.A2019409)
文摘Background Increased serum creatinine(SCr)was common after cardiac surgery and associated with poor outcomes.However,the prognostic role of postoperative SCr level measured on the morning of the first day was unclear in middle-aged and aged patients with rheumatic heart disease(RHD)undergoing valve replacement surgery(VRS).Methods Consecutive middle-aged and aged patients(age≥45 years)diagnosed with RHD undergoing at least one valve replacement were enrolled.Patients were routinely taken into the intensive care unit(ICU)for special care within 1 hour after VRS.SCr was measured at ICU admission and on the first day morning(within 24 hours).Association of postoperative SCr level with in-hospital and one-year mortality was analyzed.Results 3919 patients were finally included and divided into 4 groups according to the quartiles of postoperative SCr level on the first day morning:<1.0 mg/d L(n=1064),1.0-1.2 mg/d L(n=892),1.2-1.5 mg/d L(n=956)and≥1.5 mg/d L(n=1007).SCr level measured on the first day morning following surgery was an independent predictor for in-hospital mortality(adjusted OR:3.42,95%CI:2.52-4.63,P<0.001)and 1-year mortality(adjusted HR:2.99,95%CI:2.32-3.86,P<0.001).SCr level measured at this time had a greater predictive power for inhospital mortality than that measured at the time of ICU admission after surgery(P<0.001).Cumulative one-year mortality was significantly higher in patients with upper postoperative SCr quartiles on the first day morning(Logrank:125.75,P<0.001).Conclusions Postoperative SCr level measured on the first day morning could serve as an early and powerful prognostic marker for in-hospital and one-year mortality in middle-aged and aged RHD patients undergoing VRS.Attention should be paid to RHD patients with increased postoperative SCr level within24 hours after surgery.
文摘INTRODUCTION With the development of economy and improvement of life quality,the incidences of hypertension,hyper-cholesterolemia,diabetes,obesity and smoking have been increased in China,which has led to a significant increase in the morbidity and mortality of coronary artery disease（CAD）~1.Since it was introduced into China in 1984,coronary intervention（PCI）has developed rapidly and has become the major treatment of CAD because of its unique characteristics of minimal invasive and effective outcome.
基金supported by Science and Technology Projects of Guangdong(No.2017ZC0330)Medical science and Technology Research Funding of Guangdong(No.A2017347)
文摘Background The suitable time for treating patients with acute ST elevation myocardial infarction （STEMI） is unclear. This study was to investigate the effects of reperfusion therapy at different late times on patients with acute STEMI, in order to decide the best time for late reperfusion therapy by providing evidence-based treatment in clinical practice. Methods We enrolled 1372 patients with STEMI and receiving selective percutaneous coro- nary intervention therapy between January 1st, 2010 to December 30th, 2014. According to the time receiving PCI, these patients were divided into 3 groups： 〈3 d（n=66） ,3-6 d（n=388） and/〉7 d （n=918）. The demograph- ic, clinical and coronary angiography data, and in-hospital major adverse clinical events （MACEs） were com- pared. Results The mortality rates among 3 groups were not statistically different （0 vs. 2.6% vs. 2.0%, P= 0.375）. The incidence rate of in-hospital MACEs in 3-6 d group was lower than the other two groups, but not sta- tistic difference （25.8% vs. 16.8% vs. 21.6%, P=0.077）. By comparing the cost of hospitalization, we found that the 3-6 d group was slight lower. For patients with non-occlusive culprit vessels, although the mortality rate still had no statistic difference, the incidence rates of in-hospital MACEs were different （33.3% vs. 11.7% vs. 15.9%, P=0.003）. However, the same conclusion was not driven in patients with occlusive target vessels. Conclusions For patients with STEMI receiving late reperfusion therapy, intervention during 3-6 d might have a trend to improve prognosis.
